What Rijuven does

Rijuven is a privately held medical device company founded in 2012 and headquartered in Pittsburgh, Pennsylvania, that builds connected point-of-care diagnostic platforms for cardiac and chronic care. The product portfolio centers on three hardware systems — CardioSleeve, a digital stethoscope attachment that records and analyzes synchronized ECG and heart sound data using Systolic Time Interval (STI) measurements; Rejiva EKG, a wireless, reusable chest-worn monitor that consolidates event, Holter, and Mobile Cardiac Outpatient Telemetry functionality; and Clinic in a Bag, a portable cloud-connected examination kit for facility-grade care in remote settings. These devices feed a cloud analytics platform that runs cardiac function algorithms, arrhythmia detection across 22 types, and a 4-zone traffic-light triage system, with interoperability exposed via ABDM-compliant FHIR R4 APIs in India.

Rijuven generates revenue through hardware sales of CardioSleeve and Rejiva devices bundled with recurring cloud software subscriptions and managed care extension services (telehealth, remote patient monitoring, self-exam kits, and home health) sold primarily via direct enterprise field sales to healthcare systems, hospitals, and clinical teams. Geographic coverage spans 8 countries — the United States, India, Kenya, South Africa, UAE, Saudi Arabia, Jordan, and Nepal — and the platform is positioned for primary care, post-acute/chronic care, and remote/underserved community deployments.

The company is led by co-founder Dr. Raj Kapoor (Pulmonary/Critical Care specialist) and Evens Augustin (Carnegie Mellon engineer, Pitt MBA), with operating leadership from Taras Silecky (prior Ascension Health Ventures and Western NIS Enterprise Fund experience). Cumulative disclosed funding through 2015 totaled roughly $3.78M across six rounds, and the most recent strategic emphasis has been on clinical validation (GGH Kurnool, n=373, April 2026) and ABDM integration in India to unlock national-scale procurement.

Name

Rijuven

Legal name

Rijuven Corp.

Website

https://rijuven.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Rijuven is a privately held medical device company founded in 2012 that builds connected point-of-care diagnostic platforms — CardioSleeve, Rejiva EKG, and Clinic in a Bag — with cloud analytics and telehealth, sold via direct enterprise sales to healthcare systems and hospitals across 8 countries.

Ownership category

akta.pro rank

Product category

Connected Medical Devices / Point-of-Care Cardiac Diagnostics

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Other Computer Related Services (541519)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)

akta.pro secondary industries

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Remote Patient Monitoring (RPM) Platforms & Device Hubs (Connectivity/Gateways) (HLAHACAH), Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD)

Keywords

• Connected medical devices
• Cardiac diagnostics
• Remote patient monitoring
• Digital auscultation
• Telehealth platform

Headquarters

HQ city

Wexford

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Connected Device Hardware Sales: Rijuven generates revenue primarily through the sale of its connected medical device hardware (CardioSleeve, Rejiva Patch) bundled with cloud-based software subscriptions and analytics services. The platform supports recurring revenue from software licenses, monitoring services, and telehealth connectivity, alongside one-time hardware sales of examination platforms (Clinic in a Bag). Revenue streams span enterprise healthcare systems, hospital deployments, and care extension services.
2. Cloud Analytics & Software Platform: Cloud-based software and analytics platform providing real-time data processing, STI cardiac analysis, arrhythmia detection, telehealth connectivity, and population health monitoring on a recurring subscription basis.
3. Care Extension & Remote Monitoring Services: Care extension services including remote patient monitoring, tele-health video portal, patient-facing apps, self-exam kits, and home health services bundled as managed services for healthcare providers, hospital discharge programs, and chronic care management.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Rijuven develops and sells connected medical device platforms for cardiac diagnostics, remote patient monitoring, and chronic care management. Its core products include the CardioSleeve smart ECG stethoscope attachment, Rejiva EKG wireless cardiac monitoring patch, and Clinic in a Bag portable examination kit, all integrated with cloud-based analytics, telehealth connectivity, and the TeleFi care delivery model for healthcare systems, hospitals, and clinical teams.

Product overview

Rijuven offers a connected healthcare platform with three core hardware products and integrated cloud software. CardioSleeve is a smart ECG stethoscope attachment for cardiac screening; Rejiva EKG is a wireless monitoring patch for continuous cardiac telemetry; Clinic in a Bag is a portable diagnostic kit enabling facility-grade examinations in any setting. The TeleFi Care Extension service ties these together with telemedicine connectivity, enabling providers to examine, monitor, and manage patients remotely across primary care, cardiac care, and chronic care settings.

Differentiator

Problem solved

Functional benefit

Brands

• CardioSleeve: Smart ECG stethoscope attachment that enables digital auscultation, EKG recording, and systolic time interval analysis for heart failure screening.
• Rejiva
• Clinic in a Bag
• TeleFi

Products and services

• CardioSleeve A smart ECG stethoscope attachment that records, analyzes, and displays synchronized ECG and heart sound acoustic data in real time. Enables early heart failure screening, arrhythmia detection, and murmur analysis using digital auscultation and systolic time interval (STI) measurements. Attaches to any existing stethoscope. Validated with AUC 0.942 for HFrEF detection.
• Rejiva EKG
• Clinic in a Bag A comprehensive cloud-based examination platform combining diagnostic devices, lab work, and integrated telemedicine. Enables clinical teams to wirelessly deploy facility-grade care to patients at any point of care including remote communities, nursing homes, and patient homes. Supports offline mode for deployment in care deserts. Includes AI-powered health data analysis.
• Care Extension (TeleFi) A care delivery model combining telemedicine with in-clinic care, home-based care, and remote patient monitoring. Extends healthcare access by connecting providers to patients through video conference, patient-facing applications, self-exam kits, telehealth connectivity, and home health services. Enables care teams to examine, monitor, and manage patients at any location.

Quantifiable outcome

• CardioSleeve achieved AUC of 0.942 (PEP parameter) for detecting HFrEF (EF < 40%) against echocardiographic gold standard in 373-patient prospective study at GGH Kurnool.
• +5 more outcomes

Named customers2 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability7 records

Feature7 records

Partnerships

Four partnerships are on record, tiered core.

• Government General Hospital (GGH) Kurnool, Andhra PradeshcoreStrategic or Co-development Partner · 1 April 2026Prospective observational clinical validation study of Rijuven CardioSleeve STI measurements in 373 patients against echocardiographic assessment for HFrEF detection. Conducted as part of Andhra Pradesh Medtech Hackathon 2026. Study supersedes earlier 259-patient interim analysis. All patients underwent simultaneous CardioSleeve STI measurement and echocardiographic assessment.
• National Health Authority (NHA) — Ayushman Bharat Digital Mission (ABDM)coreTechnology or Integration · 1 January 2026CardioSleeve integrates with India's national digital health infrastructure (ABDM). Supports ABHA patient identity (14-digit health ID), HIE-CM consent-based data sharing, FHIR R4 APIs, SNOMED CT clinical terminology, LOINC observation codes, and UHI service discovery. Device must be registered in the NHA Medical Device Registry prior to production deployment in ABDM-connected HMIS.
• Andhra Pradesh Medtech Hackathon 2026coreStrategic or Co-development Partner · 1 January 2026Multi-institutional collaborative event co-hosting the CardioSleeve Clinical Validation Dashboard presentation. Brought together GGH Kurnool, Rijuven, and Andhra Pradesh health system stakeholders for prospective observational validation of CardioSleeve STI measurements against echocardiographic gold standard.
• Ramesh Hospitals, IndiacoreStrategic or Co-development Partner · 1 January 2019Prior clinical validation study (2019, n=258, Indian mixed cardiology population) for STI-based cardiac function assessment. Achieved 98.79% specificity and 70% sensitivity. Results confirmed and cross-validated by Rijuven's CardioSleeve validation dashboard against current 373-patient GGH Kurnool study.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• AliveCor: AliveCor produces KardiaMobile personal ECG devices and enterprise KardiaComplete remote cardiac monitoring services — directly comparable to Rijuven's Rejiva EKG patch in the connected ambulatory cardiac monitoring category.
• Eko Health: Eko Health manufactures AI-powered digital stethoscopes (CORE 500) with FDA-cleared cardiac and pulmonary disease detection algorithms — the most direct competitor to Rijuven's CardioSleeve in digital auscultation for primary care and cardiology.
• iRhythm Technologies: iRhythm's Zio long-term continuous cardiac monitoring patch and associated cloud analytics platform compete with Rijuven's Rejiva patch in ambulatory cardiac telemetry and arrhythmia detection.

Broad incumbents

• GE Healthcare: GE Healthcare offers enterprise patient monitoring and ECG systems across hospital systems globally — a broad incumbent whose installed hospital base competes with Rijuven's hospital channel opportunities.
• Omron Healthcare: Omron Healthcare manufactures connected blood pressure monitors, ECG devices, and vital signs wearables — a broader incumbent in the connected home cardiac and vital signs monitoring category overlapping with Rejiva.
• Philips (RPM / BioTelemetry): Philips acquired BioTelemetry to build a leading remote cardiac monitoring franchise — provides broad enterprise RPM services overlapping with Rijuven's Rejiva monitoring and TeleFi care extension model.
• 3M (Littmann CORE): 3M Littmann CORE digital stethoscope with Eko electronic core represents the established incumbent in digital auscultation — competes with CardioSleeve through a different attach model (integrated vs. accessory).

Emerging players

• HeartSciences: HeartSciences develops AI-ECG algorithms for earlier detection of heart disease using standard 12-lead ECG hardware — an emerging player in the same AI-enhanced cardiac screening category as CardioSleeve.
• Sanolla: Sanolla is an emerging digital auscultation company developing AI-powered smart stethoscope technology for primary care — explicitly named as a Rijuven competitor in the digital auscultation market.

Regional players

• Hippocratic AI / HealthArc: HealthArc and similar India-focused RPM platforms represent regional players with overlapping telehealth and remote monitoring offerings in the Indian market where Rijuven has built its strongest ABDM integration footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/rijuven
• LinkedInlinkedin.com/company/rijuven

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds6 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rijuven